IP Library › Assignment 022794/0140
Patent Assignment
Reel/Frame 022794/0140

Change of Name

Recorded: 2009-06-08 Pages: 29
Assignor
LORUS THERAPEUTICS INC.
Executed: 2007-07-10
Assignee
4325231 CANADA INC.
2 MERIDIAN ROAD, TORONTO, ONTARIO, M9W 4Z7, CANADA
Covered Property (1)
2-Indolyl Imidazo [4,5-D] Phenanthroline Derivatives and Their Use in the Treatment for Cancer
Patent: 8,148,392 →
Application: 11/915,257 →
Publication: US 2010/0168417
Related Assignments (4)
Other recorded transfers of the patent in this record — the chain of ownership.
Assignment of Assignor's Interest Nov 18, 2008
From: HUESCA, MARIO; YOUNG, AIPING H.; LEE, YOON; KHINE, AYE AYE
To: LORUS THERAPEUTICS INC.
Reel/Frame 021851/0490 →
Assignment of Assignor's Interest Jun 8, 2009
From: 4325231 CANADA INC.
To: GENESENSE TECHNOLOGIES INC.
Reel/Frame 022794/0416 →
Assignment of Assignor's Interest Jun 8, 2009
From: GENESENSE TECHNOLOGIES INC.
To: LORUS THERAPEUTICS INC.
Reel/Frame 022794/0635 →
Change of Name Sep 22, 2014
From: LORUS THERAPEUTICS INC.
To: APTOSE BIOSCIENCES INC.
Reel/Frame 033793/0620 →